Last reviewed · How we verify
adductor canal block dexmedetomidine
adductor canal block dexmedetomidine is a Small molecule drug developed by Mansoura University. It is currently in Phase 1 development.
At a glance
| Generic name | adductor canal block dexmedetomidine |
|---|---|
| Sponsor | Mansoura University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks (PHASE1, PHASE2)
- Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA (NA)
- Compare Morphine and Dexmedetomidine as Adjuvants to Bupivacaine in Ultrasound-guided ACB for Postoperative Analgesia After Knee Surgeries (PHASE1, PHASE2)
- ACB vs no Block for Pediatric ACL Reconstruction (PHASE3)
- Dexmedetomidine as an Adjunct to Periarticular Ropivacaine in Total Knee Replacement: A Pilot Randomised Controlled Trial (PHASE4)
- Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty (NA)
- Comparison Between Fentanyl and Dexmedetomidine As Adjuvant to Bupivacaine in Combined IPACK and Adductor Canal Block for Postoperative Analgesia After Knee Surgeries (NA)
- Comparing Dexamethasone With Dexmedetomidine as Additives to Bupivacaine in Adductor Canal Block for Knee Arthroscopy. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- adductor canal block dexmedetomidine CI brief — competitive landscape report
- adductor canal block dexmedetomidine updates RSS · CI watch RSS
- Mansoura University portfolio CI
Frequently asked questions about adductor canal block dexmedetomidine
What is adductor canal block dexmedetomidine?
adductor canal block dexmedetomidine is a Small molecule drug developed by Mansoura University.
Who makes adductor canal block dexmedetomidine?
adductor canal block dexmedetomidine is developed by Mansoura University (see full Mansoura University pipeline at /company/mansoura-university).
What development phase is adductor canal block dexmedetomidine in?
adductor canal block dexmedetomidine is in Phase 1.